Concepedia

Alex Cayley

AC

6

Publications

270

Citations

6

H-Index

2015

Active since

Affiliations

Pfizer (United States)(Current)

LeadScope (United States)

Steelcase (United States)

Novartis (Switzerland)

Roche (Switzerland)

Alex Cayley is an author at Pfizer (United States) specializing in public health, toxicology, and medicine.

Top concepts

Publications per year

2015–2022

6

Publications

6

Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project

Masamitsu Honma, Airi Kitazawa, Alex Cayley et al. · Mutagenesis · 2018 · 136 citations · Full text

Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained

Chris Barber, Alex Cayley, Thierry Hanser et al. · Regulatory Toxicology and Pharmacology · 2015 · 49 citations

, , +10

Management of pharmaceutical ICH M7 (Q)SAR predictions – The impact of model updates

Catrin Hasselgren, Joel P. Bercu, Alex Cayley et al. · Regulatory Toxicology and Pharmacology · 2020 · 31 citations · Full text

The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7

Robert S. Foster, Adrian Fowkes, Alex Cayley et al. · Genes and Environment · 2020 · 29 citations · Full text

Beyond adverse outcome pathways: making toxicity predictions from event networks, SAR models, data and knowledge

Thomas Ball, Chris Barber, Alex Cayley et al. · Toxicology Research · 2020 · 15 citations · Full text

, , +22

Rows per page

1–5 of 6